Sales and product deals are the type of information that should be and should have already been provided by ADO. We have been told that Bangs, Merck and EBio are incorporating Mix&Go into their products but there are no details of what income has been generated from sales to date or what future projections of the likely income stream is expected to be.
The information coming from the company is so general and short on detail that it is impossible to guage what progress,if any, is being made. If Merck are pricing their range too high then how can we expect sales to increase substantially.
These are issues that should be addressed by GC as it is no good getting signiatures on contracts if the sales resulting from these contracts do not generate much in the way of income.
ADO Price at posting:
5.8¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)